AMY OBRIEN: Open Payments
NPI 1942337597 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 42 payments from 20 companies in 2025. Trend: 2023 $525 · 2024 $931 · 2025 $1,169
Food & beverage: $1,169
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $344 |
| Boston Scientific Corporation | 2 | $170 |
| Teva Pharmaceuticals USA, Inc. | 5 | $120 |
| ABBVIE INC. | 3 | $65 |
| Alexion Pharmaceuticals, Inc. | 2 | $63 |
| GE HEALTHCARE | 2 | $43 |
| Eisai Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Neurelis, Inc. | 2 | $33 |
Products named: Fintepla, Intracept, AUSTEDO XR, UBRELVY, ULTOMIRIS, Leqembi, Briviact, VYEPTI.
Industry payments across FL — which companies pay providers there.
